Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
These observations qualified the HepG2 model to study the mechanisms described herein
Novo Nordisk filed for approval in December 2025 and the FDA is expected to make a decision in late 2026
The photoactivatable NAD+ analogue [32P]2-azido-NAD+ defines intra- and [PMID: 7487961] Laboratory literature summary: The photoactivatable NAD+ analogue [32P]2-azido-NAD+ defines intra- and inter-molecular interactions of the C-terminal domain of the
v.5(1),p.27-35
US$ 29.17
US$ 29.08
US$ 21.33
US$ 25.29
US$ 23.05
US$ 21.62
US$ 23.97
US$ 28.40
US$ 23.47
